CSL200
Wilson Disease
Phase 1/2Active
Key Facts
About CSL
CSL Limited is one of the world's largest biotechnology companies, specializing in plasma-derived therapies, vaccines, and innovative medicines. With a global presence spanning over 35 countries and employing more than 27,000 people, CSL has built a reputation for scientific excellence and operational expertise over more than a century. The company's diversified portfolio includes life-saving treatments for rare diseases, critical care medicines, and seasonal and pandemic vaccines.
View full company profileOther Wilson Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| UX701 | Ultragenyx Pharmaceutical | Phase 1/2/3 |